Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention

BACKGROUND: New COVID-19 treatments are desperately needed as case numbers continue to rise and emergent strains threaten vaccine efficacy. Cell therapy has revolutionized cancer treatment and holds much promise in combatting infectious disease, including COVID-19. Invariant natural killer T (iNKT)...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan-Ruide, Dunn, Zachary Spencer, Garcia, Gustavo, Carmona, Camille, Zhou, Yang, Lee, Derek, Yu, Jiaji, Huang, Jie, Kim, Jocelyn T., Arumugaswami, Vaithilingaraja, Wang, Pin, Yang, Lili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935266/
https://www.ncbi.nlm.nih.gov/pubmed/35313965
http://dx.doi.org/10.1186/s13287-022-02787-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935266/
https://www.ncbi.nlm.nih.gov/pubmed/35313965
http://dx.doi.org/10.1186/s13287-022-02787-2

Ejemplares similares